Tag

Nasopharyngeal Carcinoma

All articles tagged with #nasopharyngeal carcinoma

Flight ear trouble uncovers rare cancer in a 22-year-old California mom
health1 month ago

Flight ear trouble uncovers rare cancer in a 22-year-old California mom

A Hemet, California, 22-year-old mother named Aida Burkins was told her hearing issues and throat bleeding were altitude sickness after a flight; months later she was diagnosed with nasopharyngeal carcinoma, a rare head-and-neck cancer, and is undergoing chemotherapy and radiation. With two young children aged 1 and 3, she remains hopeful the cancer will shrink and she’ll be cancer-free, underscoring the importance of accurate diagnosis.

Flight-ear issue uncovers rare nasopharyngeal cancer in a 22-year-old mom
health1 month ago

Flight-ear issue uncovers rare nasopharyngeal cancer in a 22-year-old mom

A 22-year-old California mom of two noticed her ears wouldn’t pop after a flight, then developed hearing loss and throat bleeding. After months of evaluation, she was diagnosed with nasopharyngeal carcinoma, a rare cancer at the upper throat/base of the skull. She underwent chemotherapy and radiation and is finishing treatment with a hopeful prognosis, using her story to remind others that cancer can affect anyone.

Ear blockage after a flight leads to a life-changing NPC diagnosis
health1 month ago

Ear blockage after a flight leads to a life-changing NPC diagnosis

A 22-year-old California woman’s ear wouldn’t pop after a May 2025 flight, triggering months of symptoms that were initially dismissed as altitude sickness. A mass blocking her nasopharynx was later diagnosed as nasopharyngeal carcinoma (NPC), a rare cancer in the U.S. associated with Epstein-Barr virus. After biopsies and imaging, she began chemotherapy and radiation and is nearing the end of treatment, with doctors optimistic that the cancer is shrinking and she may be cancer-free.

Unpopped Ears on Flight Lead to Rare Cancer Diagnosis for 22-Year-Old Mother
health1 month ago

Unpopped Ears on Flight Lead to Rare Cancer Diagnosis for 22-Year-Old Mother

Aida Burkins, 22, was diagnosed with nasopharyngeal carcinoma after experiencing persistent ear pressure and bleeding following a flight to Chicago. Despite initial dismissals by doctors who attributed symptoms to altitude sickness, Burkins underwent multiple tests and biopsies. CT scans revealed extensive tumor involvement in her cervical lymph nodes and nasopharynx. She is currently undergoing chemotherapy and radiation, with doctors reporting significant tumor shrinkage. Burkins, a mother of two, hopes to be cancer-free and emphasizes the importance of listening to persistent symptoms.

healthcare3 years ago

FDA Approves LOQTORZI™ for All Stages of Nasopharyngeal Carcinoma Treatment

Coherus BioSciences and Junshi Biosciences have announced that the U.S. Food and Drug Administration (FDA) has approved LOQTORZI™ (toripalimab-tpzi) for the treatment of recurrent or metastatic nasopharyngeal carcinoma (NPC). LOQTORZI is the first and only FDA-approved treatment for NPC and can be used in combination with chemotherapy for first-line treatment or as monotherapy for patients with disease progression on or after platinum-containing chemotherapy, regardless of PD-L1 status. The approval was based on positive results from Phase 2 and Phase 3 studies, which showed significant improvements in progression-free survival and overall survival. LOQTORZI is a next-generation PD-1 monoclonal antibody that activates the immune system to kill tumors.